Charles Theuer, President and CEO at Tracon Pharmaceuticals, Inc. (TCON), bought 6,000 shares at $1.87 ($11K) on 2022-07-12, disclosed to the SEC on 2022-07-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $1.87 | 3,000 | $6K | 50.4% |
| 2 | $1.84 | 3,000 | $6K | 49.6% |
| Total | $1.85 avg | 6,000 | $11K | 100% |
| Filing → |
| TCON | BUY | 2023-01-19 | $11K | — | Filing → |
| TCON | BUY | 2022-12-15 | $30K | — | Filing → |
| TCON | BUY | 2022-11-22 | $20K | — | Filing → |